[1] |
Altenhöfer S, Witte I, Teiber JF, et al. One enzyme, two functions[J]. J Biol Chem, 2010, 285(32): 24398-24403.
|
[2] |
Harel M, Aharoni A, Gaidukov L, et al. Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes[J]. Nat Struct Mol Biol, 2004, 11(5): 412-419.
|
[3] |
Draganov DI, Teiber JF, Speelman A, et al. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities[J]. J Lipid Res, 2005, 46(6): 1239-1247.
|
[4] |
Teiber JF, Billecke SS, La Du BN, et al. Estrogen esters as substrates for human paraoxonases[J]. Arch Biochem Biophys, 2007, 461(1): 24-29.
|
[5] |
Khersonsky O, Tawfik DS. Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase[J]. Biochemistry, 2005, 44(16): 6371-6382.
|
[6] |
She ZG, Chen HZ, Yan Y, et al. The human paraoxonase gene cluster as a target in the treatment of atherosclerosis[J]. Antioxid Redox Signal, 2012, 16(6): 597-632.
|
[7] |
Rothem L, Hartman C, Dahan A, et al. Paraoxonases are associated with intestinal inflammatory diseases and intracellularly localized to the endoplasmic reticulum[J]. Free Radic Biol Med, 2007, 43(5): 730-739.
|
[8] |
Horke S, Witte I, Wilgenbus P, et al. Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress–induced caspase activation[J]. Circulation, 2007, 115(15): 2055-2064.
|
[9] |
Hagmann H, Kuczkowski A, Ruehl M, et al. Breaking the chain at the membrane: paraoxonase 2 counteracts lipid peroxidation at the plasma membrane[J]. FASEB J, 2014, 28(4): 1769-1779.
|
[10] |
Yu Z, Ou Q, Chen F, et al. Evaluation of the prognostic value of paraoxonase 1 in the recurrence and metastasis of hepatocellular carcinoma and establishment of a liver-specific predictive model of survival[J]. J Transl Med, 2018, 16(1): 327.
|
[11] |
Li Y, Li Y, Tang R, et al. Discovery and analysis of hepatocellular carcinoma genes using cDNA microarrays[J]. J Cancer Res Clin Oncol, 2002, 128(7): 369-379.
|
[12] |
Shakhparonov MI, Antipova NV, Shender VO, et al. Expression and intracellular localization of paraoxonase 2 in different types of malignancies[J]. Acta Naturae, 2018, 10(3): 92-99.
|
[13] |
Wang X, Xu G, Zhang J, et al. The clinical and prognostic significance of paraoxonase-2 in gastric cancer patients: immunohistochemical analysis[J]. Human Cell, 2019, 32(4): 487-494.
|
[14] |
Bacchetti T, Salvolini E, Pompei V, et al. Paraoxonase-2: A potential biomarker for skin cancer aggressiveness[J]. Eur J Clin Invest, 2021, 51(5): e13452.
|
[15] |
Bacchetti T, Sartini D, Pozzi V, et al. Exploring the role of paraoxonase-2 in bladder cancer: analyses performed on tissue samples, urines and cell cultures[J]. Oncotarget, 2017, 8(17): 28785-28795.
|
[16] |
Campagna R, Pozzi V, Giorgini S, et al. Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance[J]. Human Cell, 2023, 36(3): 1108-1119.
|